Why is Welcure Drugs falling/rising?

As of 14-Jul, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 12.28, which reflects a decrease of 0.64 or 4.95%. The stock has underperformed its sector by 5.85% today and has been on a consecutive downward trend for the last two days, resulting in a total return drop of 9.71%. Despite a strong performance over the past year, where the stock generated an impressive return of 84.38%, recent trading activity shows a significant decline in investor participation, with delivery volume falling by 77.61% compared to the five-day average. While the stock remains above its 50-day, 100-day, and 200-day moving averages, it is currently below its 5-day and 20-day moving averages, indicating a potential short-term weakness.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has outperformed the Sensex over longer periods, including a 4.33% gain over the past week compared to a 1.42% decline in the index. However, the recent downturn may be attributed to falling investor interest and liquidity issues, despite the company's strong financial results, including a significant increase in net sales and profits. The stock's high return on equity and favorable price-to-book ratio suggest a fair valuation, yet the current market sentiment appears to be weighing heavily on its price, leading to the observed decline.